Who owns CARTESIAN THERAPEUTICS INC COM NEW?
- Ticker: RNAC
- CUSIP Number: 816212302
Tip: Access positions for across all investors
Analyze quarterly positions in Cartesian Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cartesian Therapeutics stock
Who bought or sold CARTESIAN THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Siren | 572k | $9.2M | 100% | Sep 2024 |
|
| BlackRock | 424k | $6.8M | 100% | Sep 2024 |
|
| BlackRock | 408k | $11M | 100% | Jun 2024 |
|
| Citadel Advisors | 376k | $5.8M | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 309k | $5.0M | 1% | Sep 2024 |
|
| MPM Oncology Impact Management | 260k | $7.0M | 100% | Jun 2024 |
|
| Vanguard Group | 237k | $6.4M | 100% | Jun 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 200k | $3.2M | 100% | Sep 2024 |
|
| Erste Asset Management GmbH | 174k | $2.8M | 42% | Sep 2024 |
|
| State Street Corporation | 154k | $4.2M | 100% | Jun 2024 |
|
| Geode Capital Management | 136k | $2.2M | 2% | Sep 2024 |
|
| Yale University | 100k | $2.7M | 100% | Jun 2024 |
|
| Logos Global Management | 90k | $2.4M | 100% | Jun 2024 |
|
| 683 Capital Management | 75k | $1.2M | 100% | Sep 2024 |
|
| Northern Trust | 63k | $1.0M | 100% | Sep 2024 |
|
| Ikarian Capital | 52k | $841k | -78% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 50k | $798k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 35k | $939k | 100% | Jun 2024 |
|
| Sphera Funds Management | 25k | $677k | 100% | Jun 2024 |
|
| Delphi Financial | 22k | $355k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 19k | $307k | 0% | Sep 2024 |
|
| Lake Street Advisors Group | 16k | $255k | -50% | Sep 2024 |
|
| Bank of New York Mellon | 15k | $243k | -24% | Sep 2024 |
|
| Ironwood Investment Management | 15k | $236k | 100% | Sep 2024 |
|
| Twin Focus Capital Partners | 12k | $193k | 100% | Sep 2024 |
|
| Barclays | 12k | $188k | 209% | Sep 2024 |
|
| Bridgeway Capital Management | 10k | $275k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 9.3k | $150k | 9% | Sep 2024 |
|
| Freestone Capital Holdings | 8.0k | $216k | 100% | Jun 2024 |
|
| Bank of America Corporation | 7.6k | $122k | 44% | Sep 2024 |
|
| Morgan Stanley | 7.2k | $196k | 100% | Jun 2024 |
|
| Citigroup | 5.2k | $84k | 232% | Sep 2024 |
|
| New York State Common Retirement Fund | 5.1k | $82k | 0% | Sep 2024 |
|
| Johnson Financial Group | 4.6k | $74k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 4.0k | $64k | 146% | Sep 2024 |
|
| Mirae Asset Global Investments | 3.7k | $669.071500 | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 3.6k | $59k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 2.9k | $52k | 4% | Sep 2024 |
|
| Wells Fargo & Company | 2.3k | $37k | -4% | Sep 2024 |
|
| Tower Research Capital | 1.8k | $48k | 100% | Jun 2024 |
|
| Acadian Asset Management | 1.8k | $28k | 100% | Sep 2024 |
|
| Laurie Hall | 1.8k | $28k | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.7k | $27k | 123% | Sep 2024 |
|
| Summit Investment Advisors | 708.00 | $11k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 524.00 | $8.4k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 234.00 | $3.8k | 100% | Sep 2024 |
|
| Russell Investments | 152.00 | $4.1k | 100% | Jun 2024 |
|
| Amalgamated Bank | 130.00 | $2.0k | 0% | Sep 2024 |
|
| Activest Wealth Management | 66.00 | $1.1k | 0% | Sep 2024 |
|
| WR Wealth Planners | 39.00 | $628.999800 | 0% | Sep 2024 |
|
| Farther Finance Advisors | 18.00 | $289.999800 | 0% | Sep 2024 |
|
| CWM | 16.00 | $0 | 100% | Sep 2024 |
|
| SRS Capital Advisors | 12.00 | $194.000400 | 0% | Sep 2024 |
|
| Hazlett, Burt & Watson | 12.00 | $0 | 0% | Sep 2024 |
|
| NISA Investment Advisors | 11.00 | $176.999900 | -21% | Sep 2024 |
|
| Sterling Capital Management | 7.00 | $113.000300 | 100% | Sep 2024 |
|
| Parallel Advisors | 3.00 | $48.000000 | 0% | Sep 2024 |
|
| CoreCap Advisors | 1.00 | $0 | 100% | Sep 2024 |
|
Who sold out of Cartesian Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 305k | $8.2M |
| Marshall Wace | Jun 2024 | 30k | $811k |
| Renaissance Technologies | Jun 2024 | 17k | $461k |
| Cubist Systematic Strategies | Jun 2024 | 13k | $351k |
| Belvedere Trading | Jun 2024 | 10k | $9.0k |
| MetLife Investment Advisors | Jun 2024 | 2.4k | $66k |
| Point72 Asia | Jun 2024 | 1.8k | $49k |
| Point72 | Jun 2024 | 1.7k | $47k |
| National Bank Of Canada /fi/ | Jun 2024 | 40.00 | $970.000000 |
| Capital Advisors | Jun 2024 | 5.00 | $0 |
| FNY Investment Advisers | Jun 2024 | 3.00 | $0 |